Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C (C20) + retinol 1.0 for postinflammatory hyperpigmentation
ChiCTR2100051389Phase 4Recruiting
- Sponsor
- Southern Medical University Dermatology Hospital
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ascorbic acid and retinol in Post-inflammatory hyperpigmentation (PIH), sponsored by Southern Medical University Dermatology Hospital. Primary endpoints: colored patches, wrinkles and 2 more. Started Sep 2021; status: recruiting.
02
Drugs
ascorbic acidretinol
03
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on ChiCTR2100051389.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051389.